In summary, we have shown that SIGIRRΔE8 promotes human CRC through 2 synergistic mechanisms: (1) it relieves the inhibition on TLR/IL-1R signaling through its dominant negative effect on full-length SIGIRR, enhancing the activation of NFκB and mTOR. Here, IL1R1 is linked to colorectal carcinoma.